Zahra Shokri Varniab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zahra Shokri Varniab has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Ashkan Pourabhari Langroudi
Department of Urology, School of Medicine, Stanford University, Stanford, CA, USA
7 shared publications - Sahar Saeedi Moghaddam
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications - Sina Azadnajafabad
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications - Farshad Farzadfar
Tehran University of Medical Sciences
3 shared publications - Negar Rezaei
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Arezou Dilmaghani-Marand
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Elsevier in SSRN Electronic Journal
CSF Proteomics Reveals Bone Remodeling and Cellular Senescence Signatures across the Alzheimer's Disease and Lewy Body Disease Spectra
Aging-related processes extend beyond the brain and may contribute to the biological heterogeneity of neurodegenerative diseases. Using cerebrospinal fluid proteomics from healthy controls and individuals across the Alzheimer's disease and Lewy body disease spectra, we examined protein signatures related to skeletal remodeling and cellular senescence and evaluated their relationships with established biomarkers of neurodegeneration. Distinct molecular profiles emerged between disease groups, with the Alzheimer's disease spectrum characterized by synaptic signaling and calcineurin-associated proteins, whereas the Lewy body disease spectrum demonstrated enrichment of immune, coagulation, metabolic, and extracellular matrix remodeling pathways. Several proteins, including VEGFA and MMP14, were consistently implicated across bone and senescence analyses and were strongly associated with canonical cerebrospinal fluid biomarkers, suggesting convergence of these biological processes in neurodegeneration. These findings identify interconnected aging-associated pathways that extend beyond traditional Alzheimer's and Lewy body disease biomarkers and highlight candidate mechanisms for future investigation.
- 22 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCSF Proteomics Reveals Bone Remodeling and Cellular Senescence Signatures across the Alzheimer's Disease and Lewy Body Disease Spectra
Aging-related processes extend beyond the brain and may contribute to the biological heterogeneity of neurodegenerative diseases. Using cerebrospinal fluid proteomics from healthy controls and individuals across the Alzheimer's disease and Lewy body disease spectra, we examined protein signatures related to skeletal remodeling and cellular senescence and evaluated their relationships with established biomarkers of neurodegeneration. Distinct molecular profiles emerged between disease groups, with the Alzheimer's disease spectrum characterized by synaptic signaling and calcineurin-associated proteins, whereas the Lewy body disease spectrum demonstrated enrichment of immune, coagulation, metabolic, and extracellular matrix remodeling pathways. Several proteins, including VEGFA and MMP14, were consistently implicated across bone and senescence analyses and were strongly associated with canonical cerebrospinal fluid biomarkers, suggesting convergence of these biological processes in neurodegeneration. These findings identify interconnected aging-associated pathways that extend beyond traditional Alzheimer's and Lewy body disease biomarkers and highlight candidate mechanisms for future investigation.
- Open Access
- 19 March 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (16) , 9986-9995
Multimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy
Magnetic resonance imaging and two-photon intravital microscopy metrics were correlated to track Ferumoxytol-based theranostic nanoparticles targeting glioblastoma multiforme in vivo at both macroscopic and microscopic levels.
- 19 March 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (16) , 9986-9995
Open AccessMultimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy
Magnetic resonance imaging and two-photon intravital microscopy metrics were correlated to track Ferumoxytol-based theranostic nanoparticles targeting glioblastoma multiforme in vivo at both macroscopic and microscopic levels.
- Open Access
- 12 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 8504
Age of tobacco smoking initiation among Iranian adults based on National and Subnational data from the 2021 STEPS survey
Tobacco smoking is a significant global public health challenge, responsible for 8 million deaths annually. This study aimed to analyze the age of smoking initiation and its sociodemographic determinants among Iranian adults, based on data from the 2021 STEPwise approach to surveillance (STEPS) survey, to inform targeted public health interventions. The analysis of 27,874 adults revealed that the average initiation ages for cigarette and hookah smoking were 22.2 years and 24.9 years, respectively. Men typically began smoking earlier than women, with average ages of 21.9 years for males and 27.7 years for females. No significant differences were observed in smoking initiation ages between rural and urban areas. Education level and marital status were also influential, with the youngest initiators having 7-12 years of education and being single. This study highlights the significant roles of gender, education, and urban-rural differences in smoking initiation in Iran. The findings underscore the need for targeted public health strategies conforming to the WHO's MPOWER initiatives and the Framework Convention on Tobacco Control (FCTC). Increased investment in public health, focusing on education and preventive measures, is crucial to reduce early smoking initiation and its associated health risks, ultimately supporting broader health policy goals.
- 12 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 8504
Open AccessAge of tobacco smoking initiation among Iranian adults based on National and Subnational data from the 2021 STEPS survey
Tobacco smoking is a significant global public health challenge, responsible for 8 million deaths annually. This study aimed to analyze the age of smoking initiation and its sociodemographic determinants among Iranian adults, based on data from the 2021 STEPwise approach to surveillance (STEPS) survey, to inform targeted public health interventions. The analysis of 27,874 adults revealed that the average initiation ages for cigarette and hookah smoking were 22.2 years and 24.9 years, respectively. Men typically began smoking earlier than women, with average ages of 21.9 years for males and 27.7 years for females. No significant differences were observed in smoking initiation ages between rural and urban areas. Education level and marital status were also influential, with the youngest initiators having 7-12 years of education and being single. This study highlights the significant roles of gender, education, and urban-rural differences in smoking initiation in Iran. The findings underscore the need for targeted public health strategies conforming to the WHO's MPOWER initiatives and the Framework Convention on Tobacco Control (FCTC). Increased investment in public health, focusing on education and preventive measures, is crucial to reduce early smoking initiation and its associated health risks, ultimately supporting broader health policy goals.
- 30 December 2023
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 23 (1) , 881-893
Exploring metabolically healthy obesity: prevalence, characteristics, and cardiovascular risk in the Iranian population based on the STEPS 2021
Background Regarding the rapidly increasing prevalence of obesity throughout the globe, it remains a serious public health concern. A subgroup of obesity that does not meet metabolic syndrome criteria is called metabolically healthy obesity (MHO). However, whether the MHO phenotype increases cardiovascular disease (CVD) risk is controversial. This study aimed to evaluate the prevalence of MHO and its 10-year CVD risk in Iranian populations. Methods Based on the STEPS 2021 project in Iran, we collected data on 18119 Iranians 25 years and older from all 31 provinces after applying many statistical factors. Using the Framingham score, we evaluated the 10-year cardiovascular risk associated with the various MHO definition criteria for Iranian populations. Results The prevalence of MHO was 6.42% (5.93—6.91) at the national level according to the AHA-NHLBI definition, and 23.29% of obese women and 24.55% of obese men were classified as MHOs. Moreover, the MHO group was younger than the metabolically unhealthy obesity (MUO) group based on all definitions (p < 0.001). The odds ratio of MUO individuals being classified as high-risk individuals by the Framingham criteria for CVD was significantly higher than that of MHO individuals by all definitions, with a crude odds ratio of 3.55:1 based on AHA-NHLBI definition. Conclusion This study reveals a significant prevalence of MHO in the Iranian population, with approximately 25% of obese individuals classified as MHO. While MHO is associated with a lower risk of cardiovascular disease compared to MUO, MHO carries the potential for transitioning to an unhealthy state.
- 30 December 2023
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 23 (1) , 881-893
Exploring metabolically healthy obesity: prevalence, characteristics, and cardiovascular risk in the Iranian population based on the STEPS 2021
Background Regarding the rapidly increasing prevalence of obesity throughout the globe, it remains a serious public health concern. A subgroup of obesity that does not meet metabolic syndrome criteria is called metabolically healthy obesity (MHO). However, whether the MHO phenotype increases cardiovascular disease (CVD) risk is controversial. This study aimed to evaluate the prevalence of MHO and its 10-year CVD risk in Iranian populations. Methods Based on the STEPS 2021 project in Iran, we collected data on 18119 Iranians 25 years and older from all 31 provinces after applying many statistical factors. Using the Framingham score, we evaluated the 10-year cardiovascular risk associated with the various MHO definition criteria for Iranian populations. Results The prevalence of MHO was 6.42% (5.93—6.91) at the national level according to the AHA-NHLBI definition, and 23.29% of obese women and 24.55% of obese men were classified as MHOs. Moreover, the MHO group was younger than the metabolically unhealthy obesity (MUO) group based on all definitions (p < 0.001). The odds ratio of MUO individuals being classified as high-risk individuals by the Framingham criteria for CVD was significantly higher than that of MHO individuals by all definitions, with a crude odds ratio of 3.55:1 based on AHA-NHLBI definition. Conclusion This study reveals a significant prevalence of MHO in the Iranian population, with approximately 25% of obese individuals classified as MHO. While MHO is associated with a lower risk of cardiovascular disease compared to MUO, MHO carries the potential for transitioning to an unhealthy state.
- Open Access
- 4 December 2023
- Published by Wiley in Cancer Reports
- Vol. 7 (1) , e1937
The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016
Background: Cancer is most commonly associated with aging. It is necessary to gain a better understanding of cancer's trend and distribution among elderlies and provide comprehensive cancer care for this population.Aims: The aim of the current study was to show the trends in cancer incidence focusing on the population aged 60+ from 1990 to 2016 in Iran.Material and Results: We used the dataset of the Iran Cancer Registry to estimate cancer incidences by sex, age, province, and year. In order to account for incomplete data we used a two‐stage spatiotemporal model along with random intercept mixed effect models. We calculated annual age‐standardized incidence rates (ASIRs) for age groups 60+ and 5‐interval age groups. There was an increasing trend of 25.3% to 936.9% (95% uncertainty interval: 769.6–1141.8) in ASIR in the elderly in 2016. ASIR of all cancers were 889.7 (731.3–1083.6) in women and 988.1 (811.1–1205) in men in 2016, per 100 000 respectively, which had an increasing trend comparing 1990. Skin, breast, and stomach cancers in women and prostate, skin, and stomach cancers in men were the most common types in 2016. All the most incident cancer subtypes underwent an increasing trend in both sexes, except for the bladder, esophageal, and skin cancers which almost had a similar level in 1990 and 2016. Most provinces had an increasing trend in ASIR in all cancers combined from 1990 to 2016 except Zanjan with a decreasing trend.Conclusion: Regarding the persistent increasing trend of most elderly cancers' incidence, this is crucial for policymakers to establish preventive plans, determine proper resource allocation, and develop specific treatments for elderly cancer patients.
- 4 December 2023
- Published by Wiley in Cancer Reports
- Vol. 7 (1) , e1937
Open AccessThe levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016
Background: Cancer is most commonly associated with aging. It is necessary to gain a better understanding of cancer's trend and distribution among elderlies and provide comprehensive cancer care for this population.Aims: The aim of the current study was to show the trends in cancer incidence focusing on the population aged 60+ from 1990 to 2016 in Iran.Material and Results: We used the dataset of the Iran Cancer Registry to estimate cancer incidences by sex, age, province, and year. In order to account for incomplete data we used a two‐stage spatiotemporal model along with random intercept mixed effect models. We calculated annual age‐standardized incidence rates (ASIRs) for age groups 60+ and 5‐interval age groups. There was an increasing trend of 25.3% to 936.9% (95% uncertainty interval: 769.6–1141.8) in ASIR in the elderly in 2016. ASIR of all cancers were 889.7 (731.3–1083.6) in women and 988.1 (811.1–1205) in men in 2016, per 100 000 respectively, which had an increasing trend comparing 1990. Skin, breast, and stomach cancers in women and prostate, skin, and stomach cancers in men were the most common types in 2016. All the most incident cancer subtypes underwent an increasing trend in both sexes, except for the bladder, esophageal, and skin cancers which almost had a similar level in 1990 and 2016. Most provinces had an increasing trend in ASIR in all cancers combined from 1990 to 2016 except Zanjan with a decreasing trend.Conclusion: Regarding the persistent increasing trend of most elderly cancers' incidence, this is crucial for policymakers to establish preventive plans, determine proper resource allocation, and develop specific treatments for elderly cancer patients.
- Open Access
- 3 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0292348
Global and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990–2019
Background: The aim of this study was to examine the quality of care by age and gender in oesophageal cancer using Global Burden of Disease (GBD) database.Methods: Patients aged 20 and over with oesophageal cancer were included in this longitudinal study using GBD 1990–2019 data. We used the Socio-Demographic Index (SDI) to classify the regions. We used Principal Component Analysis (PCA) method to calculate the Quality of Care Index (QCI). The QCI was rescaled into a 0–100 single index, demonstrating that the higher the score, the better the QC.Results: The age-standardized QCI for oesophageal cancer dramatically increased from 23.5 in 1990 to 41.1 in 2019 for both sexes, globally. The high SDI regions showed higher QCI than the rest of the regions (45.1 in 1990 and 65.7 in 2019) whereas the low SDI regions had the lowest QCI, which showed a 4.5% decrease through the years (from 13.3 in 1990 to 12.7 in 2019). Globally, in 2019, the QCI showed the highest scores for patients aged 80–84, reported 48.2, and the lowest score for patients aged 25–29 reported 31.5, for both sexes. Globally, in 2019, age-standardized Gender Disparity Ratio (GDR) was 1.2, showing higher QCI in females than males.Conclusion: There were fundamental differences in the QCI both globally and regionally between different age groups as well as between males and females. To achieve the goal of providing high-quality services equally to people in need in all over the world, health systems need to invest in effective diagnostic services, treatments, facilities, and equipment and to plan for screening and surveillance of high-risk individuals.
- 3 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0292348
Open AccessGlobal and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990–2019
Background: The aim of this study was to examine the quality of care by age and gender in oesophageal cancer using Global Burden of Disease (GBD) database.Methods: Patients aged 20 and over with oesophageal cancer were included in this longitudinal study using GBD 1990–2019 data. We used the Socio-Demographic Index (SDI) to classify the regions. We used Principal Component Analysis (PCA) method to calculate the Quality of Care Index (QCI). The QCI was rescaled into a 0–100 single index, demonstrating that the higher the score, the better the QC.Results: The age-standardized QCI for oesophageal cancer dramatically increased from 23.5 in 1990 to 41.1 in 2019 for both sexes, globally. The high SDI regions showed higher QCI than the rest of the regions (45.1 in 1990 and 65.7 in 2019) whereas the low SDI regions had the lowest QCI, which showed a 4.5% decrease through the years (from 13.3 in 1990 to 12.7 in 2019). Globally, in 2019, the QCI showed the highest scores for patients aged 80–84, reported 48.2, and the lowest score for patients aged 25–29 reported 31.5, for both sexes. Globally, in 2019, age-standardized Gender Disparity Ratio (GDR) was 1.2, showing higher QCI in females than males.Conclusion: There were fundamental differences in the QCI both globally and regionally between different age groups as well as between males and females. To achieve the goal of providing high-quality services equally to people in need in all over the world, health systems need to invest in effective diagnostic services, treatments, facilities, and equipment and to plan for screening and surveillance of high-risk individuals.
- Open Access
- 22 June 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (7) , e3067
Burden of autism spectrum disorders in North Africa and Middle East from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
Introduction: Autism spectrum disorders (ASD) encompass a range of neurodevelopmental disorders that affect the patient's communication and behavior. There are some reports about the increasing prevalence of ASD in recent decades, mostly due to the improvement in diagnosis and screening status. Few studies suggested a lower prevalence of ASD in North Africa and Middle East compared to more developed regions. The aim of this study is to provide a comprehensive outlook of ASD in the region.Methods: We used Global Burden of Disease (GBD) data from 1990 to 2019 in North Africa and Middle East, which is one of the seven super regions of the GBD categorization. In this study, we reported the epidemiologic indices, including prevalence, incidence, and years lived with disability (YLDs) for ASD in the 21 countries of the super region. We also compared these indices between the countries based on their sociodemographic index (SDI) which was calculated according to income per capita, mean education, and fertility rate.Results: Age‐standardized prevalence rate (ASPR) of ASD in the region is 304.4 (95% uncertainty interval 251.2–366.1) per 100,000 in 2019 with less than one percentage change since 1990. Age‐standardized YLDs and incidence rates were 46.4 (30.4–67.5) and 7.7 (6.3–9.3) per 100,000 in 2019. The ASPR was 2.9 times greater in males compared to females in 2019. The highest age‐standardized prevalence, incidence, and YLD rates among the countries were seen in Iran in 2019 (370.3, 9.3, and 56.4 per 100,000, respectively). High SDI countries had higher age‐standardized YLDs rates compared to the other countries of the region.Conclusion: In conclusion, the trends of age‐standardized epidemiologic indices remained approximately steady through the years 1990–2019 in the region. Though, there was a wide discrepancy between the countries of the region. The difference of YLDs among the countries of this region is related to the SDI of the countries. Monetary and public awareness status are the SDI factors that may affect the quality of life of ASD patients in the region. This study provides valuable information for governments and health systems to implement policies for maintaining the improving trend, achieving more timely diagnosis, and bettering the supportive actions in this region.
- 22 June 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (7) , e3067
Open AccessBurden of autism spectrum disorders in North Africa and Middle East from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
Introduction: Autism spectrum disorders (ASD) encompass a range of neurodevelopmental disorders that affect the patient's communication and behavior. There are some reports about the increasing prevalence of ASD in recent decades, mostly due to the improvement in diagnosis and screening status. Few studies suggested a lower prevalence of ASD in North Africa and Middle East compared to more developed regions. The aim of this study is to provide a comprehensive outlook of ASD in the region.Methods: We used Global Burden of Disease (GBD) data from 1990 to 2019 in North Africa and Middle East, which is one of the seven super regions of the GBD categorization. In this study, we reported the epidemiologic indices, including prevalence, incidence, and years lived with disability (YLDs) for ASD in the 21 countries of the super region. We also compared these indices between the countries based on their sociodemographic index (SDI) which was calculated according to income per capita, mean education, and fertility rate.Results: Age‐standardized prevalence rate (ASPR) of ASD in the region is 304.4 (95% uncertainty interval 251.2–366.1) per 100,000 in 2019 with less than one percentage change since 1990. Age‐standardized YLDs and incidence rates were 46.4 (30.4–67.5) and 7.7 (6.3–9.3) per 100,000 in 2019. The ASPR was 2.9 times greater in males compared to females in 2019. The highest age‐standardized prevalence, incidence, and YLD rates among the countries were seen in Iran in 2019 (370.3, 9.3, and 56.4 per 100,000, respectively). High SDI countries had higher age‐standardized YLDs rates compared to the other countries of the region.Conclusion: In conclusion, the trends of age‐standardized epidemiologic indices remained approximately steady through the years 1990–2019 in the region. Though, there was a wide discrepancy between the countries of the region. The difference of YLDs among the countries of this region is related to the SDI of the countries. Monetary and public awareness status are the SDI factors that may affect the quality of life of ASD patients in the region. This study provides valuable information for governments and health systems to implement policies for maintaining the improving trend, achieving more timely diagnosis, and bettering the supportive actions in this region.
- 26 February 2023
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (3) , 321.e1-321.e7
A novel endoscopic approach for management of hutch diverticulum concomitant vesicoureteral reflux with dextranomer/hyaluronic acid copolymer injection
- 26 February 2023
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (3) , 321.e1-321.e7
A novel endoscopic approach for management of hutch diverticulum concomitant vesicoureteral reflux with dextranomer/hyaluronic acid copolymer injection
- Open Access
- 13 June 2022
- Published by Wiley in Cancer Medicine
- Vol. 11 (23) , 4624-4640
Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019
Background: Lung cancer is one of the leading cancers, with a high burden worldwide. As a developing country, Iran is facing with population growth, widespread tobacco use, demographic and epidemiologic changes, and environmental exposures, which lead to cancers becoming a severe concern of public health in Iran. We aimed to examine the burden of lung cancer and its risk factors in Iran.Methods: We utilized the Global Burden of Disease 2019 data and analyzed the total burden of the lung cancer and seven related risk factors by sex, age at national and sub‐national levels from 1990 to 2019.Results: The lung cancer age‐standardized death rate increased from 11.8 (95% Uncertainty Interval: 9.7–14.4) to 12.9 (11.9–13.9) per 100,000 between 1990 and 2019. This increase was among women from 5 (4.2–7.1) to 8 (7.2–8.8) per 100,000; in contrast, there was a decline among men from 18.5 (14.8–22.6) to 17.8 (16.2–19.4) per 100,000. The burden of lung cancer is concentrated in the advanced age groups. Smoking with 53.5% of total attributable deaths (51.0%–55.9%) was the leading risk factor. At the provincial level, there was a wide range between the lowest and highest, from 8.3 (7.0–10.0) to 19.1 (16.4–22.0) per 100,000 population in the incidence rate and from 8.7 (7.3–10.3) to 20.6 (17.7–24.0) per 100,000 population in mortality rate, respectively in Tehran and West Azerbaijan provinces in 2019.Conclusion: The increasing trend of lung cancer burden among the entire Iranian population, the inter‐provincial disparities, and the significant rise in burden of this cancer in women necessitate the urgent implementation and development of policies to prevent and manage lung cancer burden and strategies to reduce exposure to risk factors.
- 13 June 2022
- Published by Wiley in Cancer Medicine
- Vol. 11 (23) , 4624-4640
Open AccessEstimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019
Background: Lung cancer is one of the leading cancers, with a high burden worldwide. As a developing country, Iran is facing with population growth, widespread tobacco use, demographic and epidemiologic changes, and environmental exposures, which lead to cancers becoming a severe concern of public health in Iran. We aimed to examine the burden of lung cancer and its risk factors in Iran.Methods: We utilized the Global Burden of Disease 2019 data and analyzed the total burden of the lung cancer and seven related risk factors by sex, age at national and sub‐national levels from 1990 to 2019.Results: The lung cancer age‐standardized death rate increased from 11.8 (95% Uncertainty Interval: 9.7–14.4) to 12.9 (11.9–13.9) per 100,000 between 1990 and 2019. This increase was among women from 5 (4.2–7.1) to 8 (7.2–8.8) per 100,000; in contrast, there was a decline among men from 18.5 (14.8–22.6) to 17.8 (16.2–19.4) per 100,000. The burden of lung cancer is concentrated in the advanced age groups. Smoking with 53.5% of total attributable deaths (51.0%–55.9%) was the leading risk factor. At the provincial level, there was a wide range between the lowest and highest, from 8.3 (7.0–10.0) to 19.1 (16.4–22.0) per 100,000 population in the incidence rate and from 8.7 (7.3–10.3) to 20.6 (17.7–24.0) per 100,000 population in mortality rate, respectively in Tehran and West Azerbaijan provinces in 2019.Conclusion: The increasing trend of lung cancer burden among the entire Iranian population, the inter‐provincial disparities, and the significant rise in burden of this cancer in women necessitate the urgent implementation and development of policies to prevent and manage lung cancer burden and strategies to reduce exposure to risk factors.